A multicentre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate once daily doses of AIT-082 over 24 weeks in probable Alzheimer's disease patients. Protocol #082-99-006. (2000–2001)

Grant type:
CroMedica Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
CroMedica Pty Ltd